| 1 |
30641908 | IL-1β Inflammatory Cytokine-Induced TP63 Isoform ∆NP63α Signaling Cascade Contributes to Cisplatin Resistance in Human Breast Cancer Cells. | 2019 Jan 11 |
3 |
| 2 |
24552820 | Novel mechanism links p63 and cisplatin resistance. | 2014 |
1 |
| 3 |
24823795 | Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress. | 2014 Jun |
2 |
| 4 |
22672905 | Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance. | 2012 Jun 15 |
2 |
| 5 |
22951905 | Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance. | 2012 Oct 15 |
2 |
| 6 |
21127199 | The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancers. | 2011 Feb 1 |
1 |
| 7 |
21252285 | Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells. | 2011 Mar |
1 |
| 8 |
20959455 | Phosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradation. | 2010 Dec 31 |
1 |
| 9 |
17639392 | Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression. | 2008 May |
5 |
| 10 |
18418053 | U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha. | 2008 May 1 |
1 |
| 11 |
17446929 | The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. | 2007 May |
4 |
| 12 |
15608418 | p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure. | 2005 |
1 |
| 13 |
16273287 | Endogenous p63 acts as a survival factor for tumour cells of SCCHN origin. | 2005 Dec |
1 |
| 14 |
15197326 | The p53 protein family and radiation sensitivity: Yes or no? | 2004 Aug-Dec |
1 |